{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:01:05Z","timestamp":1784592065098,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006630","name":"Lung Foundation Australia","doi-asserted-by":"publisher","award":["2019 Eleanor Greenwood Memorial Grant-in-Aid for Interstitial Lung Disease Research"],"award-info":[{"award-number":["2019 Eleanor Greenwood Memorial Grant-in-Aid for Interstitial Lung Disease Research"]}],"id":[{"id":"10.13039\/501100006630","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dyspnoea is a cardinal symptom of fibrotic interstitial lung disease (ILD), with a lack of proven effective therapies. With emerging evidence of the role of facial and nasal airflow for relieving breathlessness, this pilot study was conducted to examine the feasibility of conducting a clinical trial of a handheld fan (HHF) for dyspnoea management in patients with fibrotic ILD. In this mixed-methods, randomised, assessor-blinded, controlled trial, 30 participants with fibrotic ILD who were dyspnoeic with a modified Medical Research Council Dyspnoea grade\u2009\u2265\u20092 were randomised to a HHF for symptom control or no intervention for 2 weeks. Primary outcomes were trial feasibility, change in Dyspnoea-12 scores at Week 2, and participants\u2019 perspectives on using a HHF for dyspnoea management. Study recruitment was completed within nine months at a single site. Successful assessor blinding was achieved in the fan group [Bang\u2019s Blinding Index \u2212\u00a00.08 (95% CI \u2212\u00a00.45, 0.30)] but not the control group [0.47 (0.12, 0.81)]. There were no significant between-group differences for the change in Dyspnoea-12 or secondary efficacy outcomes. During qualitative interviews, participants reported that using the HHF relieved breathlessness and provided relaxation, despite initial scepticism about its therapeutic benefit. Oxygen-experienced participants described the HHF being easier to use, but not as effective for symptomatic relief, compared to oxygen therapy. Our results confirmed the feasibility of a clinical trial of a HHF in fibrotic ILD. There was a high level of patient acceptance of a HHF for managing dyspnoea, with patients reporting both symptomatic benefits and ease of use.<\/jats:p>","DOI":"10.1038\/s41598-021-86326-8","type":"journal-article","created":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T11:06:58Z","timestamp":1616670418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["A mixed-methods pilot study of handheld fan for breathlessness in interstitial lung disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Yet H.","family":"Khor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirushallini","family":"Saravanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna Y. T.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Ryerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine F.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole S. L.","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,25]]},"reference":[{"key":"86326_CR1","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1183\/09031936.00152609","volume":"36","author":"O Nishiyama","year":"2010","unstructured":"Nishiyama, O. et al. A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis. Eur. Respir. J. 36, 1067\u20131072 (2010).","journal-title":"Eur. Respir. J."},{"key":"86326_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/resp.12945","volume":"22","author":"H Khadawardi","year":"2017","unstructured":"Khadawardi, H. & Mura, M. A simple dyspnoea scale as part of the assessment to predict outcome across chronic interstitial lung disease. Respirology 22, 501\u2013507 (2017).","journal-title":"Respirology"},{"key":"86326_CR3","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","volume":"370","author":"TE King Jr","year":"2014","unstructured":"King, T. E. Jr. et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 370, 2083\u20132092 (2014).","journal-title":"N. Engl. J. Med."},{"key":"86326_CR4","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi, L. et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N. Engl. J. Med. 370, 2071\u20132082 (2014).","journal-title":"N. Engl. J. Med."},{"key":"86326_CR5","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","volume":"380","author":"O Distler","year":"2019","unstructured":"Distler, O. et al. Nintedanib for systemic sclerosis-associated interstitial lung disease. N. Engl. J. Med. 380, 2518\u20132528 (2019).","journal-title":"N. Engl. J. Med."},{"key":"86326_CR6","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","volume":"381","author":"KR Flaherty","year":"2019","unstructured":"Flaherty, K. R. et al. Nintedanib in progressive fibrosing interstitial lung diseases. N. Engl. J. Med. 381, 1718\u20131727 (2019).","journal-title":"N. Engl. J. Med."},{"key":"86326_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S2213-2600(19)30341-8","volume":"8","author":"TM Maher","year":"2019","unstructured":"Maher, T. M. et al. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Respir. Med. 8, 147\u2013157 (2019).","journal-title":"Lancet Respir. Med."},{"key":"86326_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1164\/ajrccm\/136.1.58","volume":"136","author":"RM Schwartzstein","year":"1987","unstructured":"Schwartzstein, R. M., Lahive, K., Pope, A., Weinberger, S. E. & Weiss, J. W. Cold facial stimulation reduces breathlessness induced in normal subjects. Am. Rev. Respir. Dis. 136, 58\u201361 (1987).","journal-title":"Am. Rev. Respir. Dis."},{"key":"86326_CR9","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1164\/ajrccm\/137.6.1285","volume":"137","author":"HP Liss","year":"1988","unstructured":"Liss, H. P. & Grant, B. J. The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 137, 1285\u20131288 (1988).","journal-title":"Am. Rev. Respir. Dis."},{"key":"86326_CR10","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jpainsymman.2009.09.024","volume":"39","author":"S Galbraith","year":"2010","unstructured":"Galbraith, S., Fagan, P., Perkins, P., Lynch, A. & Booth, S. Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J. Pain. Symptom. Manag. 39, 831\u2013838 (2010).","journal-title":"J. Pain. Symptom. Manag."},{"key":"86326_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1472-684X-8-9","volume":"8","author":"MC Farquhar","year":"2009","unstructured":"Farquhar, M. C., Higginson, I. J., Fagan, P. & Booth, S. The feasibility of a single-blinded fast-track pragmatic randomised controlled trial of a complex intervention for breathlessness in advanced disease. BMC Palliat. Care. 8, 9 (2009).","journal-title":"BMC Palliat. Care."},{"key":"86326_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12916-014-0194-2","volume":"12","author":"MC Farquhar","year":"2014","unstructured":"Farquhar, M. C. et al. Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial. BMC Med. 12, 194 (2014).","journal-title":"BMC Med."},{"key":"86326_CR13","doi-asserted-by":"publisher","first-page":"1700262","DOI":"10.1183\/13993003.00262-2017","volume":"50","author":"T Luckett","year":"2017","unstructured":"Luckett, T. et al. Contributions of a hand-held fan to self-management of chronic breathlessness. Eur. Respir. J. 50, 1700262 (2017).","journal-title":"Eur. Respir. J."},{"key":"86326_CR14","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis, W. D. et al. An Official American Thoracic Society\/European Respiratory Society Statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 188, 733\u2013748 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"86326_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cct.2003.10.016","volume":"25","author":"H Bang","year":"2004","unstructured":"Bang, H., Ni, L. & Davis, C. E. Assessment of blinding in clinical trials. Control Clin. Trials. 25, 143\u2013156 (2004).","journal-title":"Control Clin. Trials."},{"key":"86326_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1378\/chest.10-0693","volume":"139","author":"J Yorke","year":"2011","unstructured":"Yorke, J. et al. Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease. Chest 139, 159\u2013164 (2011).","journal-title":"Chest"},{"key":"86326_CR17","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/thoraxjnl-2012-201581","volume":"67","author":"AS Patel","year":"2012","unstructured":"Patel, A. S. et al. The development and validation of the King\u2019s Brief Interstitial Lung Disease (K-BILD) health status questionnaire. Thorax 67, 804\u2013810 (2012).","journal-title":"Thorax"},{"key":"86326_CR18","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.jclinepi.2014.06.009","volume":"67","author":"PL Ritter","year":"2014","unstructured":"Ritter, P. L. & Lorig, K. The English and Spanish Self-Efficacy to Manage Chronic Disease Scale measures were validated using multiple studies. J. Clin. Epidemiol. 67, 1265\u20131273 (2014).","journal-title":"J. Clin. Epidemiol."},{"key":"86326_CR19","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1111\/jgs.2000.48.11.1496","volume":"48","author":"AM Yohannes","year":"2000","unstructured":"Yohannes, A. M., Roomi, J., Winn, S. & Connolly, M. J. The Manchester Respiratory Activities of Daily Living questionnaire: development, reliability, validity, and responsiveness to pulmonary rehabilitation. J. Am. Geriatr. Soc. 48, 1496\u20131500 (2000).","journal-title":"J. Am. Geriatr. Soc."},{"key":"86326_CR20","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1046\/j.1532-5415.2003.51512.x","volume":"51","author":"PS Baker","year":"2003","unstructured":"Baker, P. S., Bodner, E. V. & Allman, R. M. Measuring life-space mobility in community-dwelling older adults. J. Am. Geriatr. Soc. 51, 1610\u20131614 (2003).","journal-title":"J. Am. Geriatr. Soc."},{"key":"86326_CR21","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jpainsymman.2015.11.026","volume":"51","author":"MJ Johnson","year":"2016","unstructured":"Johnson, M. J., Booth, S., Currow, D. C., Lam, L. T. & Phillips, J. L. A mixed-methods, randomized, controlled feasibility trial to inform the design of a phase III trial to test the effect of the handheld fan on physical activity and carer anxiety in patients with refractory breathlessness. J. Pain Symptom Manag. 51, 807\u2013815 (2016).","journal-title":"J. Pain Symptom Manag."},{"key":"86326_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun, V. & Clarke, V. Using thematic analysis in psychology. Qual. Res. Psychol. 3, 77\u2013101 (2006).","journal-title":"Qual. Res. Psychol."},{"key":"86326_CR23","doi-asserted-by":"publisher","first-page":"a288","DOI":"10.1136\/bmj.a288","volume":"337","author":"A Kuper","year":"2008","unstructured":"Kuper, A., Reeves, S. & Levinson, W. An introduction to reading and appraising qualitative research. BMJ 337, a288 (2008).","journal-title":"BMJ"},{"key":"86326_CR24","doi-asserted-by":"publisher","first-page":"30629","DOI":"10.3402\/ecrj.v3.30629","volume":"3","author":"C Kohberg","year":"2016","unstructured":"Kohberg, C., Andersen, C. U. & Bendstrup, E. Opioids: an unexplored option for treatment of dyspnea in IPF. Eur. Clin. Respir. J. 3, 30629 (2016).","journal-title":"Eur. Clin. Respir. J."},{"key":"86326_CR25","first-page":"CD007354","volume":"10","author":"ST Simon","year":"2016","unstructured":"Simon, S. T. et al. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst. Rev. 10, CD007354 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"key":"86326_CR26","doi-asserted-by":"publisher","first-page":"1801270","DOI":"10.1183\/13993003.01270-2018","volume":"53","author":"DC Currow","year":"2018","unstructured":"Currow, D. C. et al. Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial. Eur. Respir. J. 53, 1801270 (2018).","journal-title":"Eur. Respir. J."},{"key":"86326_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1136\/thoraxjnl-2019-213681","volume":"75","author":"D Currow","year":"2020","unstructured":"Currow, D. et al. Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial. Thorax 75, 50\u201356 (2020).","journal-title":"Thorax"},{"key":"86326_CR28","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S2213-2600(18)30289-3","volume":"6","author":"D Visca","year":"2018","unstructured":"Visca, D. et al. Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial. Lancet Respir. Med. 6, 759\u2013770 (2018).","journal-title":"Lancet Respir. Med."},{"key":"86326_CR29","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.chest.2020.01.049","volume":"158","author":"YH Khor","year":"2020","unstructured":"Khor, Y. H. et al. Ambulatory oxygen in fibrotic ILD: a pilot, randomised, triple-blinded, sham-controlled trial. Chest 158, 234\u2013244 (2020).","journal-title":"Chest"},{"key":"86326_CR30","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1152\/jappl.1988.64.1.371","volume":"64","author":"KR Burgess","year":"1988","unstructured":"Burgess, K. R. & Whitelaw, W. A. Effects of nasal cold receptors on pattern of breathing. J. Appl. Physiol. 64, 371\u2013376 (1988).","journal-title":"J. Appl. Physiol."},{"key":"86326_CR31","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1164\/ajrccm\/144.2.419","volume":"144","author":"PM Simon","year":"1991","unstructured":"Simon, P. M. et al. Oral mucosal stimulation modulates intensity of breathlessness induced in normal subjects. Am. Rev. Respir. Dis. 144, 419\u2013422 (1991).","journal-title":"Am. Rev. Respir. Dis."},{"key":"86326_CR32","doi-asserted-by":"publisher","first-page":"e007535","DOI":"10.1136\/bmjopen-2014-007535","volume":"5","author":"MJ Johnson","year":"2015","unstructured":"Johnson, M. J. et al. Magnetoencephalography to investigate central perception of exercise-induced breathlessness in people with chronic lung disease: a feasibility pilot. BMJ Open. 5, e007535 (2015).","journal-title":"BMJ Open."},{"key":"86326_CR33","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1177\/0269216319835393","volume":"33","author":"F Swan","year":"2019","unstructured":"Swan, F. et al. Airflow relieves chronic breathlessness in people with advanced disease: an exploratory systematic review and meta-analyses. Palliat. Med. 33, 618\u2013633 (2019).","journal-title":"Palliat. Med."},{"key":"86326_CR34","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1164\/rccm.201111-2042ST","volume":"185","author":"MB Parshall","year":"2012","unstructured":"Parshall, M. B. et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am. J. Respir. Crit. Care Med. 185, 432\u2013452 (2012).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"86326_CR35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.arbres.2016.09.005","volume":"53","author":"BP Dub\u00e9","year":"2017","unstructured":"Dub\u00e9, B. P., Vermeulen, F. & Laveneziana, P. Exertional dyspnoea in chronic respiratory diseases: from physiology to clinical application. Arch. Bronconeumol. 53, 62\u201370 (2017).","journal-title":"Arch. Bronconeumol."},{"key":"86326_CR36","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1136\/postgradmedj-2015-133578","volume":"92","author":"C Chin","year":"2016","unstructured":"Chin, C. & Booth, S. Managing breathlessness: a palliative care approach. Postgrad. Med. J. 92, 393\u2013400 (2016).","journal-title":"Postgrad. Med. J."},{"key":"86326_CR37","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/j.pain.2011.03.023","volume":"152","author":"EE Krebs","year":"2011","unstructured":"Krebs, E. E. et al. Comparative mortality among Department of Veterans Affairs patients prescribed methadone or long-acting morphine for chronic pain. Pain 152, 1789\u20131795 (2011).","journal-title":"Pain"},{"key":"86326_CR38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/wvn.12086","volume":"12","author":"AV Staedtler","year":"2015","unstructured":"Staedtler, A. V. & Nunez, D. Nonpharmacological therapy for the management of neuropsychiatric symptoms of Alzheimer\u2019s disease: linking evidence to practice. Worldviews Evid. Based Nurs. 12, 108\u2013115 (2015).","journal-title":"Worldviews Evid. Based Nurs."},{"key":"86326_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12875-017-0608-2","volume":"18","author":"WC Becker","year":"2017","unstructured":"Becker, W. C. et al. Barriers and facilitators to use of non-pharmacological treatments in chronic pain. BMC Fam. Pract. 18, 41 (2017).","journal-title":"BMC Fam. Pract."},{"key":"86326_CR40","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1080\/1744666X.2018.1512406","volume":"14","author":"L Pouillon","year":"2018","unstructured":"Pouillon, L. et al. The nocebo effect: a clinical challenge in the era of biosimilars. Expert Rev. Clin. Immunol. 14, 739\u2013749 (2018).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"86326_CR41","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1177\/0004867412464717","volume":"47","author":"J Data-Franco","year":"2013","unstructured":"Data-Franco, J. & Berk, M. The nocebo effect: a clinicians guide. Aust N. Z. J. Psychiatry. 47, 617\u2013623 (2013).","journal-title":"Aust N. Z. J. Psychiatry."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86326-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86326-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86326-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T06:01:12Z","timestamp":1670047272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86326-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,25]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["86326"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-86326-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,25]]},"assertion":[{"value":"21 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.H.K. and N.S.L.G. report non-financial support from Air Liquide Healthcare, grants and personal fees from Boehringer Ingelheim, personal fees from Roche, outside the submitted work. A.E.H. reports grants from Roche, personal fees from Boehringer Ingelheim, non-financial support from BOC Healthcare and Air Liquide Healthcare, outside the submitted work. C.F.M. reports personal fees from GSK and Novartis, other from Menarini and Air Liquide Healthcare, and grants from Boehringer Ingelheim, outside the submitted work. C.J.R. reports grants and personal fees from Boehringer Ingelheim and Hoffmann-La Roche, outside the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6874"}}